Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic

AIDS Patient Care and STDs

Volumn 20, Issue 5, 2006, Pages 318-325

  Sheth, Anandi N ^a   Moore, Richard D ^a   Gebo, Kelly A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ILLICIT DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANAMNESIS; ASTHMA; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; CONFERENCE PAPER; DIABETES MELLITUS; ELDERLY CARE; FEMALE; FOOT CARE; GOOD GENERAL CONDITION; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MICROALBUMINURIA; OUTPATIENT DEPARTMENT; PAPANICOLAOU TEST; PATIENT REFERRAL; REAGIN TEST; RISK FACTOR; SMOKING; URBAN AREA; VACCINATION;

ADULT; AGED; BALTIMORE; DIABETES MELLITUS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEALTH SERVICES FOR THE AGED; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNIZATION SCHEDULE; MALE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENT CLINICS, HOSPITAL; PREVENTIVE HEALTH SERVICES; URBAN HEALTH SERVICES; VAGINAL SMEARS;

EID: 33744482550     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.318     Document Type: Conference Paper

References (33)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Gebo K, Fleishman J, Moore R. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: Trends between 1996-2000 in 12 states. J Acquir Immune Defic Syndr 2005;40:609-616.
3. Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C status in an urban HIV cohort. J Acquir Immune Defic Syndr 2003;34:165-173.
4. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286:2568-2577.
5. Valdez H, Chowdhry TK, Assad R, et al. Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999. Clin Infect Dis 2001;32:1487-1493.
6. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 2002;186:1023-1027.
7. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med 2002;113:91-98.
8. Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis 2003;36:1030-1038.
9. Ship JA, Wolff A, Selik RM. Epidemiology of acquired immune deficiency syndrome in persons aged 50 years or older. J Acquir Immune Defic Syndr 1991;4:84-88.
10. Centers for Disease Control and Prevention HIV/AIDS Surveillance Supplemental Report. 2002; Volume 1-44.
11. Centers for Disease Control and Prevention. AIDS among persons aged > or = 50 years-United States, 1991-1996. MMWR Morb Mortal Wkly Rep 1998;47:21-27.
12. Mack KA, Ory MG. AIDS and older americans at the end of the twentieth century. J Acquir Immune Defic Syndr 2003;33(Suppl 2):S68-S75.
13. Skiest DJ, Rubinstein E, Carley N, Gioiella L, Lyons R. The importance of comorbidity in HIV-infected patients over 55: A retrospective case-control study. Am J Med 1996;101:605-611.
14. Shah SS, McGowan JP, Smith C, Blum S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis 2002;35:1238-1243.
15. Adeyemi OM, Badri SM, Max B, Chinomona N, Barker D. HIV infection in older patients. Clin Infect Dis 2003;36:1347.
16. Justice AC, McGinnis KA, Atkinson JH, et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS 2004;18(Suppl 1):S49-S59.
17. Frisch M, Biggar RJ, Engels EA, Goedert JJ, for the AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in Adults. JAMA 2001;285:1736-1745.
18. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:1993-2003.
19. Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients-Association with antiretroviral therapy. Results from the DAD study. AIDS 2003;17:1179-1193.
20. Grover SA, Coupai L, Gilmore N, Mukherjee J. Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy. Am J Cardiol 2005;95:586-591.
21. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001;32:130-139.
22. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
23. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51:1-52.
24. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004;39:609-629.
25. U.S. Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Am Fam Physician 2003;67:1759-1766.
26. U.S. Preventive Services Task Force. Screening for breast cancer: Recommendations and rationale. Ann Intern Med 2002;137:344-346.
27. U.S. Preventive Services Task Force. Screening for col-orectal cancer: Recommendation and rationale. Ann Intern Med 2002;137:129-131.
28. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26:S33-S50.
29. Tedaldi EM, Baker RK, Moorman AC, et al. Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 2004;38:1478-1484.
30. Holtzman D, Powell-Griner E, Bolen JC, Rhodes L. State- and sex-specific prevalence of selected characteristics-Behavioral risk factor surveillance system, 1996 and 1997. MMWR CDC Surveill Summ 2000;49:1-39.
31. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-1713.
32. Minkoff HL, Eisenberger M, Feldman J, Burk R, Clarke L. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 1999;180:824-836.
33. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000;132:369-372.